Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
01/2006
01/03/2006US6982162 Genetically engineered microorgaism for use as diagnostic tool
01/03/2006US6982149 Fiber array and methods for using and making same
01/03/2006US6982144 Thermostable polymerases having altered fidelity and methods of identifying and using same
01/03/2006US6982029 Electrophoretic method and system having internal lane standards for color calibration
12/2005
12/29/2005WO2005124647A2 Isolation and purification of biochemicals
12/29/2005WO2005123767A1 Peptide-based compounds
12/29/2005WO2005123758A1 Method for the enrichment and characterization of phosphorylated peptides or proteins
12/29/2005WO2005086830A3 Raman-enhancing, and non-linear optically active nano-sized optical labels and uses thereof
12/29/2005WO2005077130A3 A method for the removal of aggregate proteins from recombinant samples using ion exchange chromatography
12/29/2005WO2005074436A3 Self-assembling split-fluorescent protein systems
12/29/2005WO2005051975A3 Methods for obtaining molecules with reduced immunogenicity
12/29/2005WO2004111608A8 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
12/29/2005WO2004103269A3 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia
12/29/2005US20050288220 Erythropoietin with high specific activity
12/29/2005US20050288218 Methods for treating and preventing sepsis using modified C1 inhibitor or fragments thereof
12/29/2005US20050287648 Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof
12/29/2005US20050287632 form a carboxyl-terminal amide of a desired peptide comprising contacting a substrate polypeptide and a palladium complex, where the palladium complex is a palladium(II) or palladium(IV) complex
12/29/2005US20050287618 Labeling or detecting of immobilized poly(amino acids), including peptides, polypeptides and proteins, on membranes and other solid supports;
12/29/2005US20050287518 New fluorescent dyes and peptide synthons having protected functional groups that can be selectively modified to incorporate functional molecules (e.g. a fluorescent label) following peptide synthesis; peptide biosensor; synthon with oxyamine moiety
12/29/2005US20050284764 Methods and apparatus for electrophoresis of prior-cast, hydratable separation media
12/29/2005CA2568601A1 Peptide-based compounds
12/28/2005EP1609800A1 Process for extraction of biological material
12/28/2005EP1608969A2 Separation and accumulation of subcellar components, and proteins derived therefrom
12/28/2005EP1608688A2 Branched water-soluble polymers and their conjugates
12/28/2005EP1608672A2 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production
12/28/2005EP1157029B1 Oligopeptide derivatives for the electrochemical measurement of protease activity
12/28/2005EP1025129B1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan
12/28/2005EP0991660B1 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
12/28/2005EP0839158B1 Method for purifying thrombopoietin
12/28/2005EP0642585B1 Activation of oligomerizing receptors by using fused receptor ligands
12/28/2005CN1714100A Antigen peptides
12/28/2005CN1712413A Use of tissue fibre proteinogen
12/28/2005CN1712412A Protein compound of human cell mesosome, its separation and use thereof
12/28/2005CN1233816C Recombinant yeast strain and IFN alpha-la interferon purifying process
12/28/2005CN1233654C Method for renaturing hydroxyapatite and purifying gene recombinant protein simultaneously
12/27/2005US6979723 Preparing preferential glycoprotein; obtain chemical intermediate, expose to vancomycin, an amine and formaldehyde, recover glycopeptide
12/27/2005US6979674 A sustained-release pharmaceutical formulation containing a granulocyte-colony stimulating factor (G-CSF), polyol:oil and a thickener
12/27/2005US6979538 Directed evolution of novel binding proteins
12/27/2005US6979436 metal and peptide complexes and/or combinatorial libraries preferential for opioids receptors, which can transit the blood-brain barrier and having improved bioavailability and pharmacokinetics; drug screening and design; analgesics
12/27/2005US6979390 separating proteins by applying an electric field; molecules migrate across a microchannel under the influence of the electric field from the focusing section into the separation section where their position and velocity are tracked
12/22/2005WO2005121178A2 Immunoaffinity chromatography polyol-responsive monoclonal antibodies
12/22/2005WO2005121173A1 Method for purifying erythropoietin
12/22/2005WO2005121169A2 Apoptosis-inducing polypeptides
12/22/2005WO2005121165A1 Process for protein isolation
12/22/2005WO2005121164A1 Process for the preparation of peptides
12/22/2005WO2005120700A2 Peptide purification by means of hard metal ion affinity chromatography
12/22/2005WO2005120541A1 Process for producing protein having its antihypertensive activity enhanced
12/22/2005WO2005107491A3 Multi-lectin affinity chromatography and uses thereof
12/22/2005WO2005082023A3 Heterocyclic self-immolative linkers and conjugates
12/22/2005WO2005077003A3 Pili from mycobacterium tuberculosis
12/22/2005WO2004048399A3 Skin or hair binding peptides
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050283003 Reversible immobilization of arginine-tagged moieties on a silicate surface
12/22/2005US20050282743 Molecular interactions in cells
12/22/2005US20050282222 Nematode PAN and ZP receptor-like sequences
12/22/2005US20050281719 Apparatus and method for polymer synthesis using arrays
12/22/2005DE102004027196A1 Crystallization of polymers (e.g. polyolefin, polyamide and polyurethane) and biopolymers (e.g. starch, chitin and nucleotide) comprises the utilization of an ionic fluid
12/22/2005DE102004023906A1 Verfahren zur Herstellung von chemischen Mikroarrays A process for the production of chemical microarrays
12/22/2005CA2569821A1 Process for protein isolation
12/22/2005CA2560007A1 Process for the preparation of peptides
12/21/2005EP1607384A1 Novel functional peptide nucleic acid and process for producing the same
12/21/2005EP1606623A2 Labelling agents for mass spectrometry comprising tertiary amines
12/21/2005EP1606232A1 Improved extraction process
12/21/2005EP1606049A1 Method of synthesis and testing of combinatorial libraries using microcapsules
12/21/2005EP1606047A2 System and process for the synthesis of polymers
12/21/2005EP1605772A1 Method for high throughput volumes in the fractionation of bio-molecules by chromatographic systems
12/21/2005EP1364208B1 Conjugates of defined stoichiometry
12/21/2005EP1335931B1 Derivatisation of proteins in aqueous solution
12/21/2005EP1307473B1 Purification of hbv antigens for use in vaccines
12/21/2005EP0702692B1 Regulation of antigen presentation
12/21/2005CN1232636C Method for detecting human tumor antigen P185 Her-2 and its application in diagnosing tumor
12/20/2005US6977293 Chimeric polypeptides
12/20/2005US6977292 Nucleophile-stable thioester generating compounds, methods of production and use
12/15/2005WO2005118625A1 Triazole-linked glycoamino acids and glycopeptides
12/15/2005WO2005118620A2 Methods for preparing internally constraied peptides and peptidomimetics
12/15/2005WO2005118617A2 Method for the purification of polymers carrying a lipophilic group
12/15/2005WO2005118616A1 Preparation of solid phase bound peptides or pnas
12/15/2005WO2005118615A1 Inhibitors of regiii proteins as asthma therapeutics
12/15/2005WO2005118614A1 Methods and compositions for treating neuropathic pain
12/15/2005WO2005118527A2 Fluorous capping reagents, and methods for peptide purification
12/15/2005WO2005056572A3 Clustered multi-antigenic carbohydrate constructs, methods for their preparation and uses thereof
12/15/2005WO2005005610A3 Mutant adeno-associated virus virions and methods of use thereof
12/15/2005WO2004056317A8 Compositions for the treatment and prevention of nephropathy
12/15/2005WO2004029072A3 PrPsc -INTERACTING MOLECULES AND USES THEREOF
12/15/2005US20050277586 Peptide chemically modified with polyethylene glycol
12/15/2005US20050277131 Mass spectrometry-based identification of proteins
12/15/2005US20050276798 with a histidine buffer and maltose; anti-HIV; higher concentrations, are storage stable, compatible with lyophilization, and safe to administer by intravenous injection
12/15/2005CA2568750A1 Compositions and methods for treatment of neovascular diseases
12/15/2005CA2568345A1 Inhibitors of regiii proteins as asthma therapeutics
12/14/2005EP1603936A2 Use of lectins to promote oligomerization of glycoproteins and antigenic molecules
12/14/2005EP1603931A2 Methods of evaluating glycomolecules for enhanced activities
12/14/2005EP1603541A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
12/14/2005EP1603512A2 Novel cyclosporins
12/14/2005EP1127259B1 Thromboplastin reagents and methods for preparing and using such reagents
12/14/2005EP1007666B1 Neurturin receptor
12/14/2005CN1231594C Preparation method of natural folding and secreted protein
12/14/2005CN1231580C Simplified method for extracting purified superoxide dismutase
12/14/2005CN1231135C Protein extracting and separating method from defatted cotton dregs
12/13/2005US6974884 Improved methods for synthesis of phosphinothiol reagents and novel protected reagents for use in peptide ligation
12/13/2005US6974792 Alpha 1-antitrypsin preparation as well as a method for producing the same